Projects per year
Organization profile
Organisation profile
Our department was established in 2002, and our graduate students are supervised by professors from the department of medicine and pharmacology as well. Our main goal is to educate professional researchers in the field of pharmacology, and to promote mechanism studies in our school.
The orientation of our goal is contingent upon the main research goals of our university such as cardiovascular and thrombus studies, natural products in Chinese medicine, the development and study of functional mechanisms in synthetic medicine. In accordance with clinical and pharmacological studies we also strive to strengthen the application of such studies.
Key Points of Middle and Long Term Research Plan:
(1) With the use of cloning and transfection genome-based biotechnology, we examine the different functions and effects of the target genetic polymorphism.
(2) Investigate vector transfection techniques, to better express or suppress specific genes in order to evaluate the effects of drug treatment on genes.
Fingerprint Dive into the research topics where Department of Pharmacology is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Profiles
Projects
結合奈米診斷治療、影像免疫基因圖譜與人工智慧於原發性與再復發膠質母細胞瘤之研究－開發新穎結構小分子抑制劑用來抑制血管生成和腫瘤微環境以治療原發性及復發性多型性神經膠質母細胞腦瘤患者(1/3)相對補助
8/1/19 → 7/31/20
Project: A - Government Institution › f - Other (Funded by Government)
Pharmacological Properties of Novel Natural Naphthoquinone-Based Derivatives: Focusing on Anti-Vegfr and Anti-Tumor Activities
8/1/19 → 7/31/20
Project: A - Government Institution › b - Ministry of Science and Technology
Develop the Novel Small Molecular Inhibitor to Target Angiogenesis and the Tumor Microenvironment for Primary and Recurrent Gbm Patient( I )
8/1/19 → 7/31/20
Project: A - Government Institution › b - Ministry of Science and Technology
Research Output
Author Correction: A novel ruthenium (II)-derived organometallic compound, TQ-6, potently inhibits platelet aggregation: Ex vivo and in vivo studies (Scientific Reports, (2017), 7, 1, (9556), 10.1038/s41598-017-09695-z)
Hsia, C. H., Velusamy, M., Sheu, J. R., Khamrang, T., Jayakumar, T., Lu, W. J., Lin, K. H. & Chang, C. C., Dec 1 2020, In : Scientific Reports. 10, 1, 1743.Research output: Contribution to journal › Comment/debate
Open Access
Biomass and Lipid Production Potential of an Indian Marine Algal Isolate Tetraselmis striata BBRR1
Boopathy, A. B., Jayakumar, T., Chinnasamy, S., Rajaram, M. G., Mohan, N., Nagaraj, S., Rengasamy, R., Manubolu, M., Sheu, J. R. & Chang, C. C., Jan 1 2020, In : Energies. 13, 2, 341.Research output: Contribution to journal › Article
Open Access
Circuit Integration Initiation of New Hippocampal Neurons in the Adult Brain
Yang, C. H., Di Antonio, A., Kirschen, G. W., Varma, P., Hsieh, J. & Ge, S., Jan 28 2020, In : Cell Reports. 30, 4, p. 959-968.e3Research output: Contribution to journal › Article
Open Access
1
Citation
(Scopus)